摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二氯三氟乙烷 | 306-83-2

中文名称
二氯三氟乙烷
中文别名
三氟二氯乙烷;1,1-二氯-2,2,2-三氟乙烷;氟利昂-123;2,2-二氯-1,1,1-三氟乙烷
英文名称
1,1,1-trifluoro-2,2-dichloroethane
英文别名
HCFC-123;2,2-Dichloro-1,1,1-trifluoroethane
二氯三氟乙烷化学式
CAS
306-83-2;34077-87-7
化学式
C2HCl2F3
mdl
——
分子量
152.931
InChiKey
OHMHBGPWCHTMQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    3

ADMET

代谢
成年雄性Fischer-344大鼠暴露于HCFC 123(43克/立方米或68克/立方米)或卤烷(2-溴-2-氯-1,1,1-三氟乙烷)(1.05克/立方米)空气中2小时。与特定于半抗原的抗三氟乙酰蛋白抗体发生免疫反应的蛋白质模式在暴露于HCFC 123和卤烷的大鼠肝脏中被发现是相同的。通过核磁共振(NMR)和气相色谱与质谱(GCMS)检测到,暴露于HCFC 123或卤烷的大鼠尿液中存在三氟乙酸。
Adult male Fischer-344 rats were exposed to HCFC 123 (43 g/m3 or 68 g/m3) or to halothane (2-bromo-2-2 chloro-1,1,1-trifluoroethane) (1.05 g/m3) in air for 2 hr. The pattern of proteins immunoreactive with haptens-specific anti-trifluoroacetylprotein antibodies was found to be identical in livers of the rats exposed to HCFC 123 and halothane. Trifluoroacetic acid was detected in urine of rats exposed to HCFC 123 or halothane by nuclear magnetic resonance (NMR) and by gas chromatography with mass spectrometry (GCMS).
来源:Hazardous Substances Data Bank (HSDB)
代谢
六组雄性查尔斯河CD大鼠分别暴露于0、6、31或125克/立方米的环境中(每天6小时,每周5天),持续4周。... 尿液分析表明三氟乙酸是一个主要的代谢物。
Groups of six male Charles River CD rats were exposed to 0, 6, 31, or 125 g/cu m (6 hr/day, 5 days/week) for 4 weeks. ... Urine analysis indicated the presence of trifluoroacetic acid as a major metabolite.
来源:Hazardous Substances Data Bank (HSDB)
代谢
1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷(HCFC-123)是一种氯氟烃,具有潜在的广泛应用和与之相关的人类暴露。作为1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷毒理学评估的一部分,研究了大鼠在封闭循环暴露系统中的代谢。两只雄性大鼠分别暴露6小时。在暴露开始后的48小时内监测放射性物质的排泄。在观察期间,引入室内的放射性物质的14%在尿液中回收。尿液中代谢物的排泄非常缓慢。三氟乙酸是1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷的主要代谢物,而N-三氟乙酰-2-氨基乙醇和N-乙酰-S-(2,2-二氯-1,1-二氟乙基)-L-半胱氨酸被确定为1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷的次要尿液代谢物。暴露开始后48小时,放射性代谢物与蛋白质的共价结合在肝脏中最高,其次是肾脏和肺。胰腺和睾丸(1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷肿瘤生成靶器官)中未观察到超过背景水平的共价结合。这些结果提示,在大鼠中,1,1-二氯-2,2,2-三氟-(2-(14C))-乙烷的生物转化遵循与广泛研究的结构类似物卤烷相同的途径。
... 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane (HCFC-123) is a chlorofluorohydrocarbon with potential widespread use and associated human exposure. As a part of the toxicological evaluation of 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane, its metabolism was studied in rodents in a closed recirculating exposure system. Two male rats were individually exposed for 6 hr. Excretion of radioactivity was monitored for 48 hr after the start of the exposure. Of the radioactivity introduced into the chamber, 14% was recovered in urine within the period of observation. Excretion of metabolites in the urine was very slow. Trifluoroacetic acid was the major metabolite of 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane and N-trifluoroacetyl-2-aminoethanol and N-acetyl-S-(2,2-dichloro-1,1-difluoroethyl)-L-cysteine were identified as minor urinary metabolites of 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane. Forty-eight hours after the start of the exposure, covalent binding of radioactive metabolites to protein was highest in liver followed by kidney and lung. Covalent binding above background levels was not observed in pancreas and testis, the target organs of 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane tumourigenicity. These results suggest that the biotransformation of 1,1-Dichloro-2,2,2-trifluoro-(2-(14C))-ethane in rodents follows a pathway identical to those of the extensively studied structural analogue halothane.
来源:Hazardous Substances Data Bank (HSDB)
代谢
氢氯氟烃(HCFCs)已被确定为广泛使用的氯氟烃(CFCs)的化学替代品,后者与平流层臭氧消耗有关。许多HCFCs是麻醉剂卤烷的结构类似物,可能遵循共同的生物转化途径,并与以蛋白质为中心的和其它细胞亲核物质形成加合物。将大鼠暴露于卤烷(2-溴-2-氯-1,1,1-三氟乙烷)或候选CFC替代品HCFC 123(2,2-二氯-1,1,1-三氟乙烷)的单次剂量,导致在大鼠的肝脏中形成了三氟乙酰化蛋白加合物(CF3CO-蛋白质),并且肾脏作为新的蛋白质三氟乙酰化的靶组织也形成了这种加合物。肾脏中的CF3CO-蛋白质大约占同一动物肝脏中形成的CF3CO-蛋白质的5%。肾脏内形成的CF3CO-蛋白质的量大致反映了大鼠肾脏微粒体体外代谢卤烷或HCFC 123的能力,后者大约占肝脏微粒体观察到的代谢能力的10%。通过免疫组化染色,发现肾脏中的CF3CO-蛋白质主要定位于皮质的管状段。在肝脏中,CF3CO-蛋白质的密度从中央静脉向门脉三联征方向减少。将大鼠肝脏微粒体与卤烷或HCFC 123体外孵育,导致大量CF3CO-蛋白质的形成,并忠实地复制了体内获得的肝脏CF3CO-蛋白质的模式。体外生成的CF3CO-蛋白质在免疫化学上与体内生成的CF3CO-蛋白质无法区分。谷胱甘肽(5 mM)和半胱氨酸(5 mM)几乎完全消除了CF3CO-蛋白质的形成;卤烷释放Br-和HCFC 123释放Cl-的程度大大降低。S-甲基-谷胱甘肽、N-乙酰-半胱氨酸、甲硫氨酸和N-乙酰-甲硫氨酸仅轻微影响CF3CO-蛋白质的形成或两种底物的代谢。数据表明,卤烷或像HCFC 123这样的候选CFC替代品的代谢及伴随的CF3CO-蛋白质形成不仅限于肝脏,也发生在肾脏。此外,已经开发并使用了一个体外系统来展示CF3CO-蛋白质的形成,表明以蛋白质为中心的和以谷胱甘肽为中心的亲核位点与卤烷或HCFC 123代谢中间体竞争。
Hydrochlorofluorocarbons (HCFCs) have been identified as chemical replacements of the widely used chlorofluorocarbons (CFCs) that are implicated in stratospheric ozone depletion. Many HCFCs are structural analogues of the anesthetic agent halothane and may follow a common pathway of biotransformation and formation of adducts to protein-centered and other cellular nucleophiles. Exposure of rats to a single dose of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) or of the candidate CFC substitute HCFC 123 (2,2-dichloro-1,1,1-trifluoroethane) led to the formation of trifluoroacetylated protein adducts (CF3CO-proteins) not only in the liver, but also in the kidney as a novel target tissue for protein trifluoroacetylation. CF3CO-proteins in the kidney amounted to about 5% of those formed in the liver of the same animal. The amount of CF3CO-proteins formed within the kidney was roughly reflected by the capacity of metabolism of halothane or HCFC 123 by rat kidney microsomes in vitro which amounted to about 10% of that observed with liver microsomes. By immunohistochemistry, CF3CO-proteins in the kidney were mainly localized in the tubular segments of the cortex. In the liver, the density of CF3CO-proteins decreased from the central vein towards the portal triad. In vitro incubation of rat liver microsomes with halothane or HCFC 123 resulted in extensive formation of CF3CO-proteins and reproduced faithfully the pattern of liver CF3CO-proteins obtained in vivo. CF3CO-proteins generated in vitro were immunochemically not discernible from those generated in vivo. Glutathione (5 mM) and cysteine (5 mM) virtually abolished CF3CO-protein formation; the release of Br- from halothane and Cl- from HCFC 123 was reduced to much lesser a degree. S-Methyl-glutathione, N-acetyl-cysteine, methionine, and N-acetyl-methionine only slightly affected the formation of CF3CO-proteins or metabolism of either substrate. The data suggest that metabolism and concomitant CF3CO-protein formation of halothane or of candidate CFC replacements like HCFC 123 is not restricted to the liver but also takes place in the kidney. Furthermore, an in vitro system for CF3CO-protein formation has been developed and used to show that protein-centered and glutathione-centered nucleophilic sites compete for intermediates of metabolism of halothane or of HCFC 123.
来源:Hazardous Substances Data Bank (HSDB)
代谢
2,2-二氯-1,1,1-三氟乙烷已知的人类代谢物包括三氟乙酰氯。
2,2-dichloro-1,1,1-trifluoroethane has known human metabolites that include Trifluoroacetyl chloride.
来源:NORMAN Suspect List Exchange
毒理性
  • 毒性总结
识别:HCFC-123是一种合成、不可燃、挥发性液体,用作商业和工业空调装置中的制冷剂,在气体灭火剂、泡沫发泡剂、金属和电子清洁剂中也有应用。人类暴露:普通公众暴露于HCFC-123的可能性预计很小。然而,在制造HCFC-123以及制造和使用含有该化学品的产品过程中,存在暴露的可能性。关于HCFC-123对人类影响的有限信息。有报道称,在未知水平的气态HCFC-123中单次暴露后,出现了头晕、头痛和恶心的情况,以及在5-1125 ppm(31.3-7030 mg/立方米)的HCFC-123蒸气中重复职业暴露1-4个月后,出现了明显或亚临床肝病的情况。体外高细胞毒性浓度下,HCFC-123对人淋巴细胞具有某种程度的致裂变活性。对于这种化学物质单次短暂暴露的最相关关键效应是中枢神经系统(CNS)的抑制和肾上腺素诱导的心律不齐的可能性增加。在HCFC-123水平超过5 ppm(31.3 mg/立方米)的环境中工作1-4个月的工人中发现了肝脏病变。动物研究:HCFC-123在实验动物中的急性毒性较低。吸入几分钟后,豚鼠在1000 ppm(6.25 g/立方米)的浓度下出现肝脏病变,所有测试物种在5000 ppm(31.3 g/立方米)的浓度下出现中枢神经系统(CNS)抑制,狗在20,000 ppm(125 g/立方米)的浓度下出现肾上腺素诱导的心律不齐。在大鼠和仓鼠中,吸入超过30,000 ppm(188 mg/立方米)的浓度4小时会导致严重的中枢神经系统抑制和死亡。HCFC-123不是皮肤刺激剂或致敏剂。它可以在液态时引起眼睛刺激。在为期2-39周的重复暴露吸入毒性研究中,大鼠、豚鼠、狗和猴子的主要靶器官是肝脏、下丘脑垂体性腺内分泌系统和CNS。没有证据表明HCFC-123在实验动物中具有致畸性,或在低于引起其他系统性影响的暴露水平上诱导生殖或胎儿毒性。新生大鼠和猴子在暴露于HCFC-123的母鼠中生长迟缓。HCFC-123的主要代谢物,三氟乙酸,在母鼠的乳汁中被发现。体外和体内遗传毒性测试为阴性。在大鼠的2年吸入研究中,肝脏、胰腺和睾丸的癌前病变和良性肿瘤的发生率有所增加,但没有与暴露相关的恶性肿瘤增加。
IDENTIFICATION: HCFC-123 is a synthetic, non-combustible, volatile liquid that is used as a refrigerant in commercial and industrial air conditioning installations, in gaseous fire extinguishants, as a foam blowing agent, and in metal and electronics cleaning. HUMAN EXPOSURE: Exposure to the general public to HCFC-123 is expected to be minimal. There is however, the potential for exposure during the manufacture of HCFC-123 and the manufacture and use of products containing this chemical. Limited information is available on the effects of HCFC-123 on humans. Cases of dizziness, headache and nausea have been reported following a single exposure to an unknown level of airborne HCFC-123, as well as cases of manifest or subclinical liver disease associated with repeated occupational exposures to HCFC-123 vapors at 5-1125 ppm (31.3-7030 mg/cu m) for 1-4 months. There was some evidence of clastogenic activity in human lymphocytes exposed to HCFC-123 at high cytotoxic concn in vitro. The most relevant critical effects for a single, brief exposure to this chemical are CNS depression and incr likelihood of ephinephrine induced cardiac arrythmia. Liver lesions were noted in workers exposed to HCFC-123 levels above 5 ppm(31.3 mg/cu m) for 1-4 mo. ANIMAL STUDIES: The acute toxicity of HCFC-123 in laboratory animals is low. Inhalation for a few minutes to a few hours causes liver lesions in guinea pigs at 1000 ppm (6.25 g/cu m) and central nervous system (CNS) depression in all species examined at 5000 ppm (31.3 g/cu m) and ephinephrine induced cardiac arrythmia in dogs at 20,000 ppm (125 g/cu m). In the rat and hamster, inhalation of more than 30,000 ppm (188 mg/cu m) for 4 hr causes severe CNS depression and death. HCFC-123 is not a skin irritant or sensitizer. It can cause eye irritation in liquid form. In repeated exposure inhalation toxicity studies lasting 2-39 wk in rats, guinea pigs, dogs and monkeys, the main target organs were the liver, the hypothalamic pituitary gonadal endocrine system, and the CNS. There was no evidence that HCFC-123 is teratogenic in laboratory animals or induces reproductive or fetal toxicity at levels of exposure lower than those that cause other systemic effects. Growth was retarded in neonatal rats and monkeys reared by dams exposed to HCFC-123. The main metabolite of HCFC-123, trifluoroacetic acid, was found in the milk of dams. In vitro and in vivo tests for genetic toxicity were negative. In a 2 year inhalation study in rats, there was an incr incidence of precancerous lesions and benign tumors in the liver, pancreas and testes, but no exposure related incr of malignant tumors.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 暴露途径
该物质可以通过吸入被身体吸收。
The substance can be absorbed into the body by inhalation.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 吸入症状
混淆。眩晕。嗜睡。无意识。
Confusion. Dizziness. Drowsiness. Unconsciousness.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 眼睛症状
红斑。疼痛。
Redness. Pain.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 摄入症状
见吸入。
See Inhalation.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
吸收、分配和排泄
吸收可以通过在大鼠中毒性研究中观察到的系统性效应和尿液中氟化物水平的升高来推断。HCFC 123在大鼠中已被证实会发生代谢转化。已证实与肝蛋白发生共价结合。
Absorption can be inferred from systemic effects and the elevated urinary fluoride levels seen in toxicity studies in rats. HCFC 123 has been shown to undergo metabolic transformation in rats. Covalent binding to liver protein has been demonstrated.
来源:Hazardous Substances Data Bank (HSDB)

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    二氯三氟乙烷氧气 作用下, 以102 %的产率得到三氟乙酰氯
    参考文献:
    名称:
    HCFC-123 (CF3CHCl2) 的对流层降解化学:一种提议的替代氯氟烃
    摘要:
    摘要 HCFC-123 已被提议作为部分完全卤化的氯氟烃和其他氯化烃的替代品,后者正在根据蒙特利尔议定书逐步淘汰。本文报告了实验室研究,这些研究旨在确定 HCFC-123 大气降解所涉及的反应的动力学和机械参数,并在对流层的二维全球模型中使用这些参数来评估降解过程中形成的产物的产量。实验研究利用激光闪光光解技术和时间分辨紫外吸收光谱进行动力学测量和宽带紫外吸收光谱进行产品表征。CF 3 CCl 2 O 2 自反应的速率系数已确定为 (3.6±0. 5)×10 -12 cm 3 mol -1 s -1 及其与HO 2 和NO的反应为(1.9±0.7)×10 -12 cm 3 mol -1 s -1 和(1.5-2.0)×10 -在室温下分别为 11 cm 3 mol -1 s -1 。还获得了 CF 3 CCl 2 O 2 与 C 2 H 5 O 2 反应的动力学数据,并确定了两个通道;CF
    DOI:
    10.1016/1352-2310(94)90121-x
  • 作为产物:
    描述:
    四氯乙烯氢氟酸五氟化锑 作用下, 120.0 ℃ 、1.5 MPa 条件下, 反应 7.0h, 以94.2%的产率得到二氯三氟乙烷
    参考文献:
    名称:
    一种联产制备1,1,2-三氟三氯乙烷和1,1,1- 三氟二氯乙烷的方法
    摘要:
    本发明公开了一种联产制备1,1,2‑三氟三氯乙烷和1,1,1‑三氟二氯乙烷的方法,包括如下制备过程:在反应高压釜中,先投入反应原料氢氟酸、六氯乙烷及四氯乙烯进行反应,原料氢氟酸、六氯乙烷及四氯乙烯的摩尔比为(10~40)∶(0.8~2.5)∶(1.2~3.6),然后加入催化剂进行催化作用,催化剂为金属氟化物或金属氯化物,金属氟化物包括AlF3、SbF3、SbF5、ZnF2,金属氯化物包括SbCl5,反应温度控制在30~250℃,反应时间控制在2~12h,反应压力控制在0.3~3.0Mpa,待反应结束后通过水洗、碱洗、精馏提纯,最终得到产物1,1,2‑三氟三氯乙烷和1,1,1‑三氟二氯乙烷。本合成方法原料来源丰富、比较廉价、反应收率高、反应进料容易、生成的产物容易分离提出,可以实现工业化连续生产。
    公开号:
    CN105237334B
  • 作为试剂:
    描述:
    2,2,2-三氟乙醚二氯三氟乙烷六氟化硫 作用下, 生成
    参考文献:
    名称:
    Atmospheric Chemistry of CF3CH2OCH2CF3:  UV Spectra and Kinetic Data for CF3CH(•)OCH2CF3 and CF3CH(OO•)OCH2CF3 Radicals and Atmospheric Fate of CF3CH(O•)OCH2CF3 Radicals
    摘要:
    Pulse radiolysis transient UV absorption spectroscopy was used to study the ultraviolet absorption spectra (220-320 nm) and kinetics of CF3CH(.)OCH2CF3 and CF3CH(OO .)OCH2CF3 radicals at 296 K, At 230 nm sigma(CF3CH(.)OCH2CF3) = (1.95 +/- 0.24) x 10(-18) and sigma(CF3CH(OO .)OCH2CF3) = (4.40 +/- 0.51) x 10(-18) cm(2) molecule(-1), Rate constants for the reaction of F atoms with CF3CH2OCH2CF3, the self-reactions of CF3CH(.)OCH2CF3 and CF3CH(OO .)OCH2CF3 radicals, the association reaction of CF3CH(.)OCH2CF3 radicals with O-2, and the reactions of CF3CH(OO .)OCH2CF3 radicals with NO and NO2 were (1.5 +/- 0.7) x 10(-11), (2.6 +/- 0.4) x 10(-11), (5.4 +/- 0.7) x 10(-12) (uncorrected for possible secondary chemistry), (2.3 +/- 0.3) x 10(-12), (1.45 +/- 0.4) x 10(-11), and (8.4 +/- 0.8) x 10(-12) cm(3) molecule(-1) s(-1), respectively. Using an FTIR technique, rate constants for the reaction of Cl atoms with CF3CH2OCH2CF3 and CF3C(O)OCH2CF3 were determined to be (7.1 +/- 0.9) x 10(-13) and (9.4 +/- 1.3) x 10(-16) cm(3) molecule(-1) s(-1). Finally, it was determined that the atmospheric fate of CF3CH(O .)OCH2CF3 radicals is decomposition via C-C bond scission to give CS radicals and 2,2,2-trifluoroethyl formate (CF3CH2OCHO) which occurs at a rate of approximately 7 x 10(5) s(-1). The results are discussed with respect to the atmospheric chemistry of CF3CH2OCH2CF3 and analogous compounds.
    DOI:
    10.1021/jp972933w
点击查看最新优质反应信息

文献信息

  • 合成2,3,3,3-四氟丙烯和2,3-二氯-1,1,1-三氟丙烷的方法
    申请人:福建永晶科技股份有限公司
    公开号:CN111187143B
    公开(公告)日:2022-09-16
    本发明涉及制备化合物2,3,3,3‑四氟丙烯(1234yf)的新方法。化合物1234yf是最新的制冷剂,其OPD(臭氧消耗潜势)为零,GWP(全球变暖潜势)为零。因此,本发明的方法涉及卡宾生成途径,用于制备化合物2,3,3,3‑四氟丙烯(1234yf)、化合物243db(2,3‑二氯‑1,1,1‑三氟丙烷)、以及任选地通过卡宾路线制备化合物2‑氯‑1,1,1‑三氟丙烯(1233xf)和化合物243db(2,3‑二氯‑1,1,1‑三氟丙烷)。本发明还涉及制备化合物2,3,3,3‑四氟丙烯(1234yf)的方法,其中化合物243db(2,3‑二氯‑1,1,1‑三氟丙烷)用作起始材料,用于制备化合物2,3,3,3‑四氟丙烯(1234yf)。
  • 一种卤代乙酰氯的光氧化制备方法
    申请人:浙江衢化氟化学有限公司
    公开号:CN109180466B
    公开(公告)日:2021-03-09
    本发明公开了一种卤代乙酰氯的光氧化制备方法,将卤代烷烃与氧源混合汽化后通入反应器进行光氧化反应得到卤代乙酰氯,光氧化反应的温度为5~60℃,物料停留时间为1~50s,氧源与卤代烷烃的摩尔比为0.1~5:1,反应器内设置有石英冷阱,石英冷阱由石英内壳和石英外壳构成,石英内壳内部设置有光源,石英内壳和石英外壳之间构成双层冷阱夹套,双层冷阱夹套内充有循环流动的滤光液,该滤光液将所述光源产生的小于300nm波段的紫外光滤去。本发明具有工艺简单、收率高、安全环保、可连续化操作的优点。
  • Method and apparatus for transforming chemical fluids using halogen or oxygen in a photo-treatment process
    申请人:Tarancon Gregorio
    公开号:US20050087434A1
    公开(公告)日:2005-04-28
    A method of treatment of reactant fluids such as hydrochlorofluorocarbons (HCFCs), hydrofluorocarbons (HFCs), hydrochlorocarbons (HCCs), and hydrocarbons (HCs) for the production of new chemical fluids. Another method of treatment for the transformation of the reactant fluids having impurities present in the chlorofluorocarbons (CFCs) or fluorocarbons (FCs) for yielding a high quality chemical product. Reactant fluids with impurities present in used CFC or FC may form an azeotropic mixture. A photochemical reaction is used wherein the reactant fluids are molecules with hydrogen atoms in a hydrogen-carbon bond. The process is comprised of the following steps: placing the reactant fluids into a process compartment of the photochemical reactor; placing halogen fluid or oxygen fluid into the process compartment of the photochemical reactor, wherein the halogen fluid is selected from a group consisting of chlorine (Cl 2 ), bromine (Br 2 ) and iodine (I 2 ); and irradiating the fluids and the halogen or oxygen fluid using radiant energy from lamps operating in the visible and ultraviolet light regions of the electromagnetic spectrum to conduct thermolysis, photolysis and photochemical treatment by halogenating or oxidizing the molecules of the reactant fluids with the halogen or oxygen fluids to form halogenated or oxidized fluids during a dwell time period.
    一种处理反应流体,如氢氯氟烃(HCFCs)、氢氟烃(HFCs)、氢氯烃(HCCs)和碳氢化合物(HCs)以生产新的化学流体的方法。另一种处理含有氯氟烃(CFCs)或氟烃(FCs)中存在的杂质的反应流体以产生高质量化学产品的方法。在使用的CFC或FC中存在的杂质的反应流体可能形成共沸混合物。所使用的是光化学反应,其中反应流体是氢原子在氢碳键中的分子。该过程包括以下步骤:将反应流体放入光化学反应器的处理室中;将卤素流体或氧气流体放入光化学反应器的处理室中,其中卤素流体选自由氯(Cl2)、溴(Br2)和碘(I2)组成的组;并且使用在电磁频谱的可见光和紫外光区域运行的灯的辐射能照射流体和卤素或氧气流体,以进行热解、光解和通过卤素化或氧化卤素或氧气流体中的反应流体分子进行光化学处理,在停留时间期间形成卤素化或氧化流体。
  • 一种三氟乙酸的制备方法
    申请人:淄博飞源化工有限公司
    公开号:CN109096087A
    公开(公告)日:2018-12-28
    本发明公开了一种三氟乙酸的制备方法,包括如下步骤:(1)1,1,1‑三氟‑2‑氯乙烷和氯气汽化后进入装有催化剂的固定床反应器,气相氯化反应合成1,1,1‑三氟‑2,2‑二氯乙烷;(2)1,1,1‑三氟‑2,2‑二氯乙烷和氧气汽化后,在光源作用下氧化反应得到三氟乙酰氯,未反应的1,1,1‑三氟‑2,2‑二氯乙烷冷凝后返回到反应器;(3)三氟乙酰氯水解得到三氟乙酸。本发明具有工艺简单、收率高、三废少等优点,而且反应转化率高,选择性高,反应连续生产,安全环保。
  • 一种1,1,1,4,4,4-六氟-2-丁烯的制备方法
    申请人:江苏蓝色星球环保科技股份有限公司
    公开号:CN107586251A
    公开(公告)日:2018-01-16
    本发明涉及一种1,1,1,4,4,4‑六氟‑2‑丁烯的制备方法,一种1,1,1,4,4,4‑六氟‑2‑丁烯的制备方法,包括以下步骤,(1)以1,1,1‑三氟氯乙烷和/或1,1,1‑三氟‑2,2‑二氯乙烷为原料,以氯气为催化剂,在光照下反应产生1,1,1,4,4,4‑六氟‑2,2,3,3‑四氯丁烷;(2)将步骤(1)得到的1,1,1,4,4,4‑六氟‑2,2,3,3‑四氯丁烷用锌粉脱氯制得1,1,1,4,4,4‑六氟‑2,3‑二氯丁烯;(3)将步骤(2)得到的1,1,1,4,4,4‑六氟‑2,3‑二氯丁烯在氢化催化剂存在下与氢气反应得到1,1,1,4,4,4‑六氟‑2‑丁烯。本发明催化剂原料易得且中间产物可以通过多条路径获得最终产品,收率高。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台